Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-22-004459
Filing Date
2022-02-14
Accepted
2022-02-14 16:29:26
Documents
14
Period of Report
2022-01-25
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8ka.htm   iXBRL 8-K/A 55146
2 ex10-1.htm EX-10.1 22712
  Complete submission text file 0001493152-22-004459.txt   319058

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT foxw-20220125.xsd EX-101.SCH 4143
4 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT foxw-20220125_def.xml EX-101.DEF 27947
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT foxw-20220125_lab.xml EX-101.LAB 38691
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT foxw-20220125_pre.xml EX-101.PRE 26562
8 EXTRACTED XBRL INSTANCE DOCUMENT form8ka_htm.xml XML 7326
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39891 | Film No.: 22632856
SIC: 2834 Pharmaceutical Preparations